NO972798L - Intravaginale medikamentleveringsanordninger for administrasjon av 17<beta>-östradiolforlöpere - Google Patents

Intravaginale medikamentleveringsanordninger for administrasjon av 17<beta>-östradiolforlöpere

Info

Publication number
NO972798L
NO972798L NO972798A NO972798A NO972798L NO 972798 L NO972798 L NO 972798L NO 972798 A NO972798 A NO 972798A NO 972798 A NO972798 A NO 972798A NO 972798 L NO972798 L NO 972798L
Authority
NO
Norway
Prior art keywords
beta
administration
drug delivery
delivery devices
intravaginal drug
Prior art date
Application number
NO972798A
Other languages
English (en)
Other versions
NO972798D0 (no
NO316707B1 (no
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of NO972798D0 publication Critical patent/NO972798D0/no
Publication of NO972798L publication Critical patent/NO972798L/no
Publication of NO316707B1 publication Critical patent/NO316707B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19972798A 1994-12-19 1997-06-17 Intravaginal medikamentleveringsanordning, fremgangsmate for fremstilling derav samt anvendelse NO316707B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05
PCT/IE1995/000063 WO1996019196A1 (en) 1994-12-19 1995-12-19 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS

Publications (3)

Publication Number Publication Date
NO972798D0 NO972798D0 (no) 1997-06-17
NO972798L true NO972798L (no) 1997-08-19
NO316707B1 NO316707B1 (no) 2004-04-13

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972798A NO316707B1 (no) 1994-12-19 1997-06-17 Intravaginal medikamentleveringsanordning, fremgangsmate for fremstilling derav samt anvendelse

Country Status (19)

Country Link
US (1) US5855906A (no)
EP (1) EP0799025B1 (no)
JP (1) JPH10510825A (no)
CN (1) CN1138526C (no)
AR (1) AR002010A1 (no)
AT (1) ATE178204T1 (no)
AU (1) AU692659B2 (no)
CA (1) CA2207622C (no)
DE (1) DE69508791T2 (no)
DK (1) DK0799025T3 (no)
ES (1) ES2133841T3 (no)
FI (1) FI119414B (no)
GR (1) GR3030614T3 (no)
IL (1) IL116433A (no)
NO (1) NO316707B1 (no)
NZ (1) NZ298490A (no)
PE (1) PE62796A1 (no)
TR (1) TR199501599A2 (no)
WO (1) WO1996019196A1 (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
PT981327E (pt) * 1997-05-07 2003-02-28 Galen Chemicals Ltd Dispositivos intravaginais de libertacao de farmacos para a administracao de testosterona e percursores da testosterona
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
ES2400091T3 (es) 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Dispositivo de suministro de fármacos intravesical y método
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
EP3566742A1 (en) 2005-10-13 2019-11-13 Synthes GmbH Drug-impregnated encasement
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2698143C (en) 2007-06-26 2016-01-19 Warner Chilcott Company, Llc Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
BRPI0917135A2 (pt) * 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
MX2011013539A (es) 2009-06-26 2012-02-28 Taris Biomedical Inc Tabletas de farmaco solidas para dispositivos implantables para administrar farmacos.
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
CN103917202B (zh) 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 眼插入件装置和方法
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
BR112015022433B1 (pt) 2013-03-15 2022-06-21 Taris Biomedical Llc Dispositivo de liberação de droga intravesical
JP6456935B2 (ja) 2013-06-21 2019-01-23 デピュイ・シンセス・プロダクツ・インコーポレイテッド フィルム及び製造方法
HUE051336T2 (hu) 2013-08-19 2021-03-01 Taris Biomedical Llc Többadagos gyógyszeradagoló eszköz
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA2944436C (en) * 2014-04-01 2023-08-22 Poly-Med, Inc. Contraceptive and related device
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
EP3285850A1 (en) 2015-04-23 2018-02-28 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
US5855906A (en) 1999-01-05
JPH10510825A (ja) 1998-10-20
AU692659B2 (en) 1998-06-11
ES2133841T3 (es) 1999-09-16
ATE178204T1 (de) 1999-04-15
NZ298490A (en) 1999-11-29
TR199501599A2 (tr) 1996-07-21
FI119414B (fi) 2008-11-14
CA2207622A1 (en) 1996-06-27
GR3030614T3 (en) 1999-10-29
IL116433A0 (en) 1996-03-31
DE69508791D1 (de) 1999-05-06
WO1996019196A1 (en) 1996-06-27
DE69508791T2 (de) 1999-12-02
AR002010A1 (es) 1998-01-07
FI972579A0 (fi) 1997-06-17
NO972798D0 (no) 1997-06-17
EP0799025A1 (en) 1997-10-08
CN1138526C (zh) 2004-02-18
IL116433A (en) 2002-02-10
AU4399196A (en) 1996-07-10
CA2207622C (en) 2006-10-17
NO316707B1 (no) 2004-04-13
FI972579A (fi) 1997-06-17
DK0799025T3 (da) 1999-10-18
PE62796A1 (es) 1996-12-28
CN1170353A (zh) 1998-01-14
EP0799025B1 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
NO972798L (no) Intravaginale medikamentleveringsanordninger for administrasjon av 17&lt;beta&gt;-östradiolforlöpere
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
MX9101175A (es) Composicion farmaceutica para administracion nasal
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
NO975931D0 (no) Blanding for administrering av medikament
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
IT8348149A0 (it) Formulazione farmaceutica di clometacina per somministrazione orale eprocedimento di preparazione
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
FI970331A (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
FI97944B (fi) Vaikuttavaa ainetta luovuttava laite
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
NO950134D0 (no) Formuleringer for oralt administrerte farmasöytiske midler
FR2660192B1 (fr) Formulation liposomiales pour l&#39;administration topique ou vaginale de medicaments.
ZA9510787B (en) Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors
FR2702960B1 (fr) Leurre pour l&#39;administration orale de médicaments vétérinaires.
AU3961693A (en) Compositions and devices for the intrauterine administration of drugs
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
FR2602680B1 (fr) Compositions pharmaceutiques pour l&#39;administration par voie nasale
SE9000204D0 (sv) Implantabel anordning foer lokal administration av laekemedel
GB9017999D0 (en) Device for the administration of pharmacologically active substances
NO930017D0 (no) Innretning for oral administrering av vaeske
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
ITMI941408A0 (it) Formulazione a rilascio modificato per la somministrazione di farmaci antiinfiammatori non steroidei